Explore the latest Q2 earnings results from major U.S. insurance companies, highlighting mixed performances amid evolving market dynamics and regulatory shifts.

Kinsale Capital Group reports 24% net income growth in Q3, driven by robust underwriting and a 25% rise in investment income, while keeping catastrophe losses low.

Selective Insurance reported Q3 earnings below analyst estimates despite revenue growth. Market impact and future outlook for this property and casualty insurer analyzed.

Truist Financial experiences shifts in institutional investments amid mixed earnings and maintains a moderate buy analyst consensus with a 4.4% dividend yield. Key insights into stock performance and investor activity.

Kansas City Life Insurance Company resolves class action lawsuits that impeded its sale, with core earnings at $0.77 per share and projected future earnings of $3 to $4, indicating financial stabilization.

Barclays, Cincinnati Financial, and LendingClub topped Q2 earnings expectations, showing strong growth and attractive valuations in banking, insurance, and consumer lending sectors.

UnitedHealth Group's stock has fallen 50% amid sector-wide challenges and regulatory scrutiny. The upcoming earnings report and guidance will be pivotal for investor confidence.

Pediatrix Medical Group to report Q2 2025 results with focus on operational performance, regulatory compliance, and revenue cycle management strategies impacting healthcare insurers and providers.

Q1 earnings season reveals mixed financial performance among major U.S. reinsurance companies, highlighting industry cyclicality, catastrophe risk exposure, and market dynamics affecting underwriting margins and stock valuations.

Progressive's personal auto insurance policies in force hit a record 25.7 million in June 2025, showing strong year-over-year growth amid a competitive U.S. market.